Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-16

FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer Healthcare LLC.)

View source ↗

Summary

FDA approved a supplemental application for Claritin RediTabs (loratadine) from Bayer Healthcare LLC. Claritin RediTabs is an antihistamine medication used to t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Claritin RediTabs (Loratadine)

Snippet

SUPPL AP for CLARITIN REDITABS (LORATADINE)